Sector Chart Thiogenesis Therapeutics, Corp.

Stocks

TTI

CA88410L1022

Biotechnology & Medical Research

Market Closed - Toronto S.E. 22:14:14 17/09/2026 +03			5-day change	1st Jan Change
0.5000 ^CAD	0.00%		-1.96%	-23.08%

08-07	Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-13	Thiogenesis Therapeutics Receives Fda Rare Pediatric Disease Designation for Tti-0102 for the Treatment of Leigh Syndrome	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
THIOGENESIS THERAPEUTICS, CORP.	25.11M	-	-	-	-	-
LONZA GROUP AG	45.91B
IQVIA HOLDINGS INC.	44.25B
REVOLUTION MEDICINES, INC.	41.99B	-	-	-	-	-
BEONE MEDICINES AG	39.58B
CELLTRION, INC.	31.08B